Erratum: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors.
Front Pharmacol
; 15: 1443537, 2024.
Article
in En
| MEDLINE
| ID: mdl-38974038
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2024.1361424.].
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2024
Document type:
Article
Country of publication: